All Companies

ABBVCongressional Stock Trades

ABBVIE INC.

Pharmaceutical Preparations

Congressional stock trades in ABBVIE INC. (ABBV) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.

Total Trades

38

Politicians Trading

14

Last Traded

Sep 14, 2026

Trading History

PoliticianNotifiedTradedTypeAmountChange
Pete SessionsRSep 18, 2026Sep 14, 2026Sell$15,001 - $50,000+10.34%
Ro KhannaDJul 6, 2026Jun 2, 2026Buy$1,001 - $15,000+34.09%
Ro KhannaDJun 9, 2026May 15, 2026Buy$15,001 - $50,000+37.29%
Ro KhannaDJun 9, 2026May 1, 2026Buy$15,001 - $50,000+39.81%
Josh GottheimerDJun 3, 2026May 5, 2026Sell$1,001 - $15,000+40.14%
Ro KhannaDMay 11, 2026Apr 13, 2026Sell$15,001 - $50,000+39.89%
Julie JohnsonDJan 15, 2026Dec 18, 2025Sell$1,001 - $15,000+29.63%
Julia LetlowRJan 13, 2026Dec 8, 2025Sell$1,001 - $15,000+29.46%
Julia LetlowRJan 13, 2026Apr 28, 2025Buy$1,001 - $15,000+50.17%
Julia LetlowRJan 13, 2026Jan 24, 2025Sell$1,001 - $15,000+69.61%
Julie JohnsonDDec 11, 2025Nov 13, 2025Sell$1,001 - $15,000+24.34%
Lisa C. McClainRNov 21, 2025Oct 31, 2025Sell$1,001 - $15,000+32.47%
Lisa C. McClainRNov 21, 2025Oct 30, 2025Buy$1,001 - $15,000+26.57%
Lisa C. McClainRNov 21, 2025Oct 30, 2025Sell$1,001 - $15,000+26.57%
Julie JohnsonDSep 11, 2025Aug 14, 2025Sell$1,001 - $15,000+41.12%
Ritchie TorresDAug 20, 2025Jul 11, 2025Sell$1,001 - $15,000+50.09%
Marjorie Taylor GreeneRAug 15, 2025Aug 4, 2025Buy$1,001 - $15,000+46.48%
Lisa C. McClainRAug 13, 2025Jul 22, 2025Sell$1,001 - $15,000+54.37%
Lisa C. McClainRAug 13, 2025Jul 22, 2025Buy$1,001 - $15,000+54.37%
Lisa C. McClainRAug 13, 2025Jun 17, 2025Buy$1,001 - $15,000+55.73%
Josh GottheimerDJun 11, 2025May 22, 2025Buy$1,001 - $15,000+58.23%
Robert BresnahanRJun 9, 2025May 15, 2025Buy$1,001 - $15,000+58.98%
Josh GottheimerDMay 14, 2025Apr 17, 2025Sell$1,001 - $15,000+66.97%
Josh GottheimerDMay 14, 2025Apr 3, 2025Buy$1,001 - $15,000+43.25%
Josh GottheimerDMay 14, 2025Apr 1, 2025Buy$1,001 - $15,000+40.03%
Jared MoskowitzDMay 9, 2025Apr 7, 2025Buy$1,001 - $15,000+54.83%
Jefferson ShreveRMay 8, 2025Apr 17, 2025Sell$50,001 - $100,000+66.97%
Robert BresnahanRMay 8, 2025Apr 8, 2025Sell$1,001 - $15,000+64.42%
Marjorie Taylor GreeneRMay 6, 2025May 5, 2025Buy$1,001 - $15,000+47.31%
Dwight EvansDApr 17, 2025Apr 3, 2025Sell$1,001 - $15,000+43.25%
Robert BresnahanRMar 27, 2025Feb 25, 2025Buy$1,001 - $15,000+41.49%
Marjorie Taylor GreeneRMar 19, 2025Mar 17, 2025Buy$1,001 - $15,000+34.68%
Jefferson ShreveRMar 9, 2025Feb 24, 2025Buy$50,001 - $100,000+41.53%
Jared MoskowitzDFeb 10, 2025Jan 15, 2025Buy$1,001 - $15,000+68.57%
Jared MoskowitzDFeb 10, 2025Jan 15, 2025Buy$1,001 - $15,000+68.57%

Price History

About ABBVIE INC.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

FAQ

14 members of Congress have disclosed 38 trades in ABBVIE INC. (ABBV). Most active: Lisa C. McClain (6), Josh Gottheimer (5), Ro Khanna (4).

Across all disclosures, members of Congress reported 20 purchases and 18 sales of ABBVIE INC. (ABBV). The most recent trade was on Sep 14, 2026.

Ro Khanna disclosed buying ABBVIE INC. (ABBV) on Jun 2, 2026, valued at $1,001 - $15,000.

Pete Sessions disclosed selling ABBVIE INC. (ABBV) on Sep 14, 2026, valued at $15,001 - $50,000.

From House and Senate periodic transaction reports filed under the STOCK Act. Members of Congress must disclose trades within 45 days, and amounts are reported as ranges, not exact values.